Literature DB >> 17709714

Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.

Bilal Saulat1, Paul Maertens, William J Hamilton, Bassam A Bassam.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709714     DOI: 10.1212/01.wnl.0000267694.45244.f4

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 2.  Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.

Authors:  Sanjeev Rajakulendran; Stuart Viegas; Jennifer Spillane; Robin S Howard
Journal:  J Neurol       Date:  2012-09-07       Impact factor: 4.849

3.  Juvenile Generalized Myasthenia Gravis With AChR and MuSK Antibody Double Positivity: A Case Report With a Review of the Literature.

Authors:  XiuShan Ge; CuiJie Wei; Hui Dong; YueHua Zhang; XinHua Bao; Ye Wu; DanYu Song; HongJun Hao; Hui Xiong
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

4.  Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.

Authors:  Anna Kostera-Pruszczyk; Hubert Kwiecinski
Journal:  J Neurol       Date:  2009-06-23       Impact factor: 4.849

5.  Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies.

Authors:  Kazuhiro Horiuchi; Azusa Nagai; Masahiro Wakita; Shotaro Ito; Kei Takamura; Hideki Houzen
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

Review 6.  Complicating autoimmune diseases in myasthenia gravis: a review.

Authors:  Aliona Nacu; Jintana Bunpan Andersen; Vitalie Lisnic; Jone Furlund Owe; Nils Erik Gilhus
Journal:  Autoimmunity       Date:  2015-04-27       Impact factor: 2.815

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.